advanced search

INDUSTRIALISATION

MITIGATING RISK TO DELIVER SUCCESS IN HIGH-VOLUME WEARABLE DEVICES
WEARABLES
Catherine Thacker
MITIGATING RISK TO DELIVER SUCCESS IN HIGH-VOLUME WEARABLE DEVICES
Catherine Thacker and Bill Jaworski discuss risk reduction solutions in the manufacturing architecture for wearable injectors, including an example where autonomous intelligent vehicles and ATS‘s real-time industrial IoT manufacturing intelligence system, Illuminate®, were employed.
PERSONALISING DRUG PRODUCTS USING 3D PRINTING
EARLY INSIGHT
Sarah Trenfield
FabRx
PERSONALISING DRUG PRODUCTS USING 3D PRINTING
Sarah Trenfield and Abdul Basit look at the potential applications of 3D-printing technology to create personalised drug therapies in fields such as multiple drug therapy and paediatric/geriatric care and introduce FabRx’s 3D-printing system, which can produce formulations to suit a variety of situations.
EXPANDING AUTOMATION CAPACITY FOR HIGH AND LOW VOLUMES
INDUSTRIALISATION
Gilbert Fluetsch
SHL Medical
EXPANDING AUTOMATION CAPACITY FOR HIGH AND LOW VOLUMES
Gilbert Fluetsch and Lucy Chung look at how automation and assembly services can best evolve and adapt to industry standards and market demands, whilst delivering consistently at high quality and in a timely manner.
Z.BLIZZARD AUTOMATION SYSTEM – IT DOESN’T GET MORE TAILOR-MADE THAN THIS
INDUSTRIALISATION
Berthold Schopferer
Z.BLIZZARD AUTOMATION SYSTEM – IT DOESN’T GET MORE TAILOR-MADE THAN THIS
Berthold Schopferer explains how the Zahoransky’s integrated syringe manufacturing and assembly equipment allows maximum customisation and full customer involvement.
3D PRINTING DRUGS: LEARNING FROM THE PIONEERS
EXPERT VIEW
Jamie Clayton
3D PRINTING DRUGS: LEARNING FROM THE PIONEERS
Jamie Clayton reviews the potential of 3D printing as a pharmaceutical production method and looks at the associated implications for formulation development, focusing on powder-based printing. He examines what leading experts now understand about how to specify powder feeds for 3D printing.
COMPACTION SIMULATION / INDUSTRIAL PRESS CORRELATION: TWO CASE STUDIES
EXPERT VIEW
Dr Aline Moulin
COMPACTION SIMULATION / INDUSTRIAL PRESS CORRELATION: TWO CASE STUDIES
Aline Moulin and Lucile Kowalski examine two case studies comparing compaction simulation with industrial compression.
INDUSTRIALISATION OF INHALATION PRODUCTS: OVERCOMING HURDLES AT COMMERCIAL SCALE
EXPERT VIEW
Robin Heath
INDUSTRIALISATION OF INHALATION PRODUCTS: OVERCOMING HURDLES AT COMMERCIAL SCALE
Robin Heath discusses the typical challenges in scaling-up drug products from small-scale production to commercial manufacturing – and how these can be overcome.
Bob Tilling, Kallik
INTERVIEW
Bob Tilling
Bob Tilling, Kallik
In this interview, Bob Tilling, Business Development Manager at Kallik, shares his insights on best practice for factory labelling.
A FIVE-STEP APPROACH TO INNOVATION IN DRUG DELIVERY SYSTEMS
INDUSTRIALISATION
Michael Wiglenda
Gerresheimer
A FIVE-STEP APPROACH TO INNOVATION IN DRUG DELIVERY SYSTEMS
Michael Wiglenda explains Gerresheimer’s industrialisation offering and the five-step Gate-Model that guides its innovation process.
QUALI-V EXTRA DRY: A NOVEL CAPSULE FOR DELIVERING HYGROSCOPIC FORMULATIONS
INDUSTRIALISATION
Jose Luis Encinas
Qualicaps
QUALI-V EXTRA DRY: A NOVEL CAPSULE FOR DELIVERING HYGROSCOPIC FORMULATIONS
Jose Luis Encinas and Susana Ecenarro explore how the use of Quali-V® Extra Dry capsules can help improve product stability and, crucially, lead to efficiencies and savings in drug product manufacture.
AUTOMATING PREVIOUSLY IMPOSSIBLE MANUAL INSPECTIONS USING MACHINE LEARNING & CONCURRENT VALIDATION
INDUSTRIALISATION
Steve Wardell
AUTOMATING PREVIOUSLY IMPOSSIBLE MANUAL INSPECTIONS USING MACHINE LEARNING & CONCURRENT VALIDATION
Steve Wardell and Catherine Thacker explore how machine learning technology is enabling the automation of challenging, or previously impossible, manual inspections.
PRODUCT SHOWCASE: Zwickroell Autoinjector Testing Platform
INJECTION
Wolfgang Moersch
ZwickRoell
PRODUCT SHOWCASE: Zwickroell Autoinjector Testing Platform
ZwickRoell introduces RoboTest, its automated autoinjector testing platform, which works together with the AutoEdition 3 automation software ad testXpert III testing software.
NEXT-LEVEL FUTURE MANUFACTURING FOR MEDICAL TECHNOLOGY
INJECTION
Berthold Schopferer
NEXT-LEVEL FUTURE MANUFACTURING FOR MEDICAL TECHNOLOGY
Berthold Schopferer explains the lengths the production equipment company goes to in its efforts to ensure the customer is always king.
AUTOMATING UNDER UNCERTAINTY – GOOD PRACTICES
EXPERT VIEW
Simon Drexler
AUTOMATING UNDER UNCERTAINTY – GOOD PRACTICES
Simon Drexler discusses lessons learned and good practices when dealing with uncertainty at the various stages of automation development for drug delivery device manufacturing.
GUILLAUME BROUET, APTAR PHARMA
INTERVIEW
Guillaume Brouet
Aptar Pharma
GUILLAUME BROUET, APTAR PHARMA
Guillaume Brouet talks with ONdrugDelivery Magazine about how Aptar Pharma uses its device development expertise and infrastructure to provide its pharmaceutical company customers a comprehensive services offering around device development, global regulatory approval and commercialisation.
PAUL ALLSOP, MILES KOTTMAN, HANNAH PRIESTLY & JON REED, CONSORT GROUP
INTERVIEW
Paul Allsop
Bespak
PAUL ALLSOP, MILES KOTTMAN, HANNAH PRIESTLY & JON REED, CONSORT GROUP
Consort Medical's Paul Allsop, Miles Kottman, Hannah Priestly and Jon Reed talk with ONdrugDelivery Magazine about the company’s integrated formulation and device offering, and focus on its simple, low-cost, single unit-dose, spring powered nasal device, Unidose Xtra.
SYNERGISING EXCIPIENTS TO BOOST SKIN DELIVERY
SKIN
Cécile Morin
SYNERGISING EXCIPIENTS TO BOOST SKIN DELIVERY
Cécile Morin and Delphine Marchaud discuss combining polar and apolar excipients in topical formulations in order produce synergies that maximise the performance of the drug.
ORAL THIN FILMS: NOVEL TECHNOLOGY & ITS CHALLENGES
EXPERT VIEW
Dr Nidhi Prakash Sapkal
ORAL THIN FILMS: NOVEL TECHNOLOGY & ITS CHALLENGES
Presented from both the technology and formulation perspectives, Nidhi Prakash Sapkal and Anwar Siraj Daud discuss the challenges of industrialising oral thin films, a promising but difficult dosage form.
BEYOND MANUFACTURING: INDUSTRIALISATION OF DRUG DELIVERY IN THE REAL WORLD
EXPERT VIEW
Napoleon Monroe
BEYOND MANUFACTURING: INDUSTRIALISATION OF DRUG DELIVERY IN THE REAL WORLD
When discussing the industrialisation of drug delivery, it is natural to focus on the processes and management of manufacture. Napoleon Monroe provides a different perspective on the idea of drug delivery’s “Industrialisation” and what that might mean in the modern world of service industry.
INDUSTRIALISING DRUG DELIVERY SYSTEMS – A RISK-BASED APPROACH
INDUSTRIALISATION
Catherine Thacker
INDUSTRIALISING DRUG DELIVERY SYSTEMS – A RISK-BASED APPROACH
Catherine Thacker and Tom Hayes discuss ATS Automation’s methodology for developing a manufacturing strategy for a drug delivery device, from fresh design to mass-produced product.
MEASURING THE INFLUENCE OF TALC ON THE PROPERTIES OF LACTOSE POWDERS
INDUSTRIALISATION
Dr Quentin Ribeyre
Granutools
MEASURING THE INFLUENCE OF TALC ON THE PROPERTIES OF LACTOSE POWDERS
Quentin Ribeyre et al describe how three of the company’s instruments can be used to characterise powder properties and behaviour, exemplified by experiments investigating the effects of adding talc to different lactose grades.
THE BIGGEST MISTAKES COMPANIES MAKE COMMERCIALISING DRUG DELIVERY – AND WHAT TO DO ABOUT THEM
EXPERT VIEW
Beth Blackburn
THE BIGGEST MISTAKES COMPANIES MAKE COMMERCIALISING DRUG DELIVERY – AND WHAT TO DO ABOUT THEM
It is difficult to successfully scale-up a product to industrial production and launch, but it is much harder if design fundamentals are not adhered to. Beth Blackburn details the need for setting down requirements early in device development in order to avoid inadvertently undermining a product’s successful commercialisation.
A “KODAK” MOMENT FOR THE PHARMA INDUSTRY?
EXPERT VIEW
Dr Pari Datta
A “KODAK” MOMENT FOR THE PHARMA INDUSTRY?
Pari Datta and Nick Rollings discuss the concept of personalised medicine, with particular reference to oncology, and how it represents both an opportunity and a threat.
A COMPREHENSIVE APPROACH TO PHARMA INDUSTRIALISATION PARTNERING
INDUSTRIALISATION
Michael Wiglenda
Gerresheimer
A COMPREHENSIVE APPROACH TO PHARMA INDUSTRIALISATION PARTNERING
As a company offering contract services at every stage of drug delivery system development, Gerresheimer has a wealth of expertise and history in industrial-scale production. Michael Wiglenda explains Gerresheimer’s industrialisation offering in detail.
Top